Suppr超能文献

在老年男性和女性中,前蛋白转化酶枯草杆菌蛋白酶/克新9型的血浆水平与N端前B型利钠肽呈负相关。

Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Inversely Associated with N-Terminal Pro B-Type Natriuretic Peptide in Older Men and Women.

作者信息

Spannella Francesco, Giulietti Federico, Galeazzi Roberta, Passarelli Anna, Re Serena, Di Pentima Chiara, Allevi Massimiliano, Magni Paolo, Sarzani Riccardo

机构信息

Internal Medicine and Geriatrics, IRCCS INRCA, 60129 Ancona, Italy.

Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, 60126 Ancona, Italy.

出版信息

Biomedicines. 2022 Aug 12;10(8):1961. doi: 10.3390/biomedicines10081961.

Abstract

BACKGROUND AND AIMS

Cardiac natriuretic peptides (NPs) exert several metabolic effects, including some on lipid metabolism. Higher NPs levels are likely to be associated with a favorable lipid profile. In in vitro studies, NPs have been found to modulate low-density lipoprotein receptor (LDLR) trafficking by preventing proprotein convertase subtilisin/kexin type 9 (PCSK9) overexpression. The aim of our study is to investigate a possible association between plasma levels of PCSK9 and N-terminal pro B-type natriuretic peptide (NT-proBNP) in vivo.

METHODS

We performed a cross-sectional study on 160 consecutive older male and female patients hospitalized for medical conditions. Patients taking lipid-lowering drugs and patients with an admission diagnosis of acute heart failure were excluded. Fasting blood samples were collected after clinical stabilization of the acute illness, the day before discharge.

RESULTS

The mean age was 87.8 ± 6.4 years with a female prevalence (62.5%). The median NT-proBNP was 2340 (814-5397) pg/mL. The mean plasma PCSK9 was 275.2 ± 113.2 ng/mL. We found an inverse correlation between plasma PCSK9 and NT-proBNP (r = -0.280; = 0.001). This association was confirmed after taking into account NT-proBNP tertiles (plasma PCSK9 levels: 317.4 ± 123.6 ng/mL in the first tertile, 283.3 ± 101.8 ng/mL in the second tertile, 231.3 ± 99.0 ng/mL in the third tertile, = 0.001) and even after an adjustment for confounding factors (beta = -0.361, = 0.001 for ln(NT-proBNP); beta = -0.330, = 0.001 for NT-proBNP tertiles). The strength of the correlation between plasma PCSK9 and NT-proBNP was likely greater in patients affected by type 2 diabetes mellitus (r = -0.483; = 0.006) and in male patients (r = -0.431, = 0.001).

CONCLUSION

The inverse association found between PCSK9 and NT-proBNP plasma levels in our real-life clinical study supports the hypothesis that NPs may play a role in cholesterol metabolism, possibly through an inhibitory action on circulating PCSK9 concentrations, thus increasing the availability of LDLR.

摘要

背景与目的

心脏利钠肽(NPs)具有多种代谢作用,包括对脂质代谢的一些作用。较高的NPs水平可能与良好的血脂谱相关。在体外研究中,已发现NPs通过防止前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9)过表达来调节低密度脂蛋白受体(LDLR)的转运。我们研究的目的是在体内研究PCSK9血浆水平与N末端B型利钠肽原(NT-proBNP)之间可能存在的关联。

方法

我们对160例因内科疾病住院的连续老年男性和女性患者进行了横断面研究。排除服用降脂药物的患者和入院诊断为急性心力衰竭的患者。在急性疾病临床稳定后、出院前一天采集空腹血样。

结果

平均年龄为87.8±6.4岁,女性患病率为62.5%。NT-proBNP中位数为2340(814 - 5397)pg/mL。血浆PCSK平均水平为275.2±113.2 ng/mL。我们发现血浆PCSK9与NT-proBNP之间呈负相关(r = -0.280;P = 0.001)。在考虑NT-proBNP三分位数后(第一三分位数血浆PCSK9水平:317.4±123.6 ng/mL,第二三分位数:283.3±101.8 ng/mL,第三三分位数:231.3±99.0 ng/mL,P = 0.001),甚至在对混杂因素进行调整后(ln(NT-proBNP)的β = -0.361,P = 0.001;NT-proBNP三分位数的β = -0.330,P = 0.001),这种关联仍得到证实。在2型糖尿病患者(r = -0.483;P = 0.006)和男性患者(r = -0.431,P = 0.001)中,血浆PCSK9与NT-proBNP之间的相关性强度可能更大。

结论

在我们的实际临床研究中发现PCSK9与NT-proBNP血浆水平之间存在负相关,这支持了NPs可能在胆固醇代谢中起作用的假设,可能是通过对循环中PCSK9浓度的抑制作用,从而增加LDLR的可用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3647/9405766/31afdb082d36/biomedicines-10-01961-g001.jpg

相似文献

2
N-terminal pro B-Type natriuretic peptide is inversely correlated with low density lipoprotein cholesterol in the very elderly.
Nutr Metab Cardiovasc Dis. 2018 Jun;28(6):629-635. doi: 10.1016/j.numecd.2018.02.013. Epub 2018 Feb 27.
3
Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure.
JACC Heart Fail. 2024 Mar;12(3):461-474. doi: 10.1016/j.jchf.2023.09.011. Epub 2023 Oct 25.
4
Correlation between B type natriuretic peptide and metabolic risk factors.
Arch Med Sci. 2016 Apr 1;12(2):334-40. doi: 10.5114/aoms.2015.57001. Epub 2016 Jan 12.
6
ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
Nutr Metab Cardiovasc Dis. 2015 Apr;25(4):411-7. doi: 10.1016/j.numecd.2014.10.015. Epub 2014 Nov 5.
7
Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD.
Nutr Metab Cardiovasc Dis. 2020 Sep 24;30(10):1820-1825. doi: 10.1016/j.numecd.2020.05.017. Epub 2020 Jun 2.
8
Effect of empagliflozin on plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with type 2 diabetes.
Diabetes Res Clin Pract. 2022 Aug;190:109983. doi: 10.1016/j.diabres.2022.109983. Epub 2022 Jul 6.
9
Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.
Diabetologia. 2006 Oct;49(10):2256-62. doi: 10.1007/s00125-006-0359-4. Epub 2006 Aug 26.

引用本文的文献

3
Role of Cardiac Natriuretic Peptides in Heart Structure and Function.
Int J Mol Sci. 2022 Nov 20;23(22):14415. doi: 10.3390/ijms232214415.

本文引用的文献

1
Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease.
Front Cardiovasc Med. 2021 Oct 1;8:713191. doi: 10.3389/fcvm.2021.713191. eCollection 2021.
2
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
3
PCSK9 is not secreted from mature differentiated intestinal cells.
J Lipid Res. 2021;62:100096. doi: 10.1016/j.jlr.2021.100096. Epub 2021 Jul 17.
4
PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction.
Eur Heart J. 2021 Aug 21;42(32):3078-3090. doi: 10.1093/eurheartj/ehab431.
5
Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels and Cardiometabolic Risk Factors: A Population-Based Cohort Study.
Front Cardiovasc Med. 2021 May 10;8:664583. doi: 10.3389/fcvm.2021.664583. eCollection 2021.
6
PCSK9 levels do not predict severity and recurrence of cardiovascular events in patients with acute myocardial infarction.
Nutr Metab Cardiovasc Dis. 2021 Mar 10;31(3):880-885. doi: 10.1016/j.numecd.2020.11.010. Epub 2020 Nov 20.
7
PCSK9: Associated with cardiac diseases and their risk factors?
Arch Biochem Biophys. 2021 Jun 15;704:108717. doi: 10.1016/j.abb.2020.108717. Epub 2020 Dec 9.
8
Elevated levels of serum PCSK9 in male patients with symptomatic peripheral artery disease: The CAVASIC study.
Atherosclerosis. 2021 Jan;316:41-47. doi: 10.1016/j.atherosclerosis.2020.11.025. Epub 2020 Nov 28.
10
Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes.
Atherosclerosis. 2020 Jan;293:49-56. doi: 10.1016/j.atherosclerosis.2019.11.027. Epub 2019 Nov 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验